INTLGNT BIO SOL (INBS)
(Delayed Data from NSDQ)
$1.50 USD
-0.02 (-1.32%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $1.50 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
INBS 1.50 -0.02(-1.32%)
Will INBS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for INBS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for INBS
INBS Stock May Rise on SMARTOX Partnership Expanding Forensic Reach
Intelligent Bio Solutions Stock Drops Despite Key U.S. Patent Win
INBS: What are Zacks experts saying now?
Zacks Private Portfolio Services
INBS Stock Declines Despite Positive Results of Pharmacokinetic Study
Other News for INBS
INBS Secures Major Contract with London Transport Operator
Intelligent Bio secures major drug testing tender with transport operator
Intelligent Bio Solutions secures drug testing tender with a London transport operator
Intelligent Bio Solutions Secures Major Drug Testing Tender with Leading London Transport ...
Intelligent Bio Solutions (INBS) Announces Warrant Exercise Agreement | INBS Stock News